Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF130 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | HNRNPA1L2 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | ZNF276 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | ZNF195 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | ZIC2 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | TEAD3 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | FOXD3 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | CSF2RB | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-05 |
mRNA | ARID2 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | NAGK | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |